In this section you can familiarize yourself with the latest scientific discoveries and studies proving the effectiveness of using medical cannabis in the treatment of a wide variety of disorders and diseases.

You can find the archive of works in the encyclopedia.

• Name: Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
• Country: USA
• Authors: Zinah Zamil Al-Ghezi, Kathryn Miranda, Mitzi Nagarkatti, and Prakash S. Nagarkatti
• Date: 21 August 2019

• Name: Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation
• Country: Canada
• Authors: Anthony Murkar, Pam Kent, Christian Cayer, Jon James, Tony Durst, and Zul Merali
• Date: 2019 Aug 1

• Name: Opportunities for cannabis in supportive care in cancer
• Country: USA
• Authors: Amber S. Kleckner, Ian R. Kleckner, Charles S. Kamen, Mohamedtaki A. Tejani, Michelle C. Janelsins, Gary R. Morrow, and Luke J. Peppone
• Date: 1 August 2019

• Name: Acute and short-term administrations of delta-9-tetrahydrocannabinol modulate major gut metabolomic regulatory pathways in C57BL/6 mice
• Country: USA
• Authors: Megha Oza, William Becker, Phani M. Gummadidala, Travis Dias
• Date: 2019 Jul 19

• Name: Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms
• Country: Spain
• Authors: Claudia Calpe-López, M. Pilar García-Pardo, and Maria A. Aguilar
• Date: 2019 Jul 16

• Name: A survey of veterinary student attitudes concerning whether marijuana could have therapeutic value for animals
• Country: Canada
• Authors: Nadine A. Vogt, Jan M. Sargeant, Jennifer N. Dunn
• Date: 2019 Jul 8

• Name: Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study
• Country: Canada
• Authors: Richard J. Huntsman, Richard Tang-Wai, Jane Alcorn, Stephanie Vuong, Bryan Acton, Scott Corley, Robert Laprairie
• Date: 2019 Jul 3

• Name: Cannabis use in active athletes: Behaviors related to subjective effects
• Country: United States of America
• Authors: Joanna S. Zeiger, William S. Silvers, Edward M. Fleegler and Robert S. Zeiger
• Date: 2019 Jun 28

• Name: Association between medical cannabis laws and opioid overdose mortality has reversed over time
• Country: USA
• Authors: Chelsea L. Shover, Corey S. Davis, Sanford C. Gordon, and Keith Humphreysa
• Date: jun 2019

• Name: Safety and Efficacy of Medical Cannabis in Fibromyalgia
• Country: Israel
• Authors: Iftach Sagy, Lihi Bar-Lev Schleider, Mahmoud Abu-Shakra, and Victor Novack
• Date: 2019 Jun 5

• Name: Pros and Cons of Marijuana in Treatment of Parkinson’s Disease
• Country: USA
• Authors: Rikinkumar S Patel, Saher Kamil, Mansi R Shah, Narmada Neerja Bhimanadham, and Sundus Imran
• Date: 2019 Jun 3

• Name: Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
• Country: France
• Authors: Julia De Ternay, Mickaël Naassila, Mikail Nourredine, Alexandre Louvet, François Bailly
• Date: 2019 May 31

• Name: Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
• Country: USA
• Authors: Zinah Zamil Al-Ghezi, Kathryn Miranda, Mitzi Nagarkatti, and Prakash S. Nagarkatti
• Date: 2019 Aug 21

• Name: Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies
• Country: Germany
• Authors: Katja Akgün, Ute Essner, Cordula Seydel, and Tjalf Ziemssen
• Date: 2019 Mar 11

• Name: The Association between Cannabis Product Characteristics and Symptom Relief
• Country: USA
• Authors: Sarah S. Stith, Jacob M. Vigil,corresponding author Franco Brockelman, Keenan Keeling, and Branden Hall
• Date: 2019 Feb 25

• Name: A Review of Cannabis in Chronic Kidney Disease Symptom Management
• Country: Canada
• Authors: Claudia Ho, Dan Martinusen, and Clifford Lo
• Date: 2019 Feb 22

• Name: Striking lung cancer response to self-administration of cannabidiol: A case report and literature review
• Country: UK
• Authors: Josep Sulé-Suso, Nick A Watson, Daniel G van Pittius, and Apurna Jegannathen
• Date: 2019 Feb 21

• Name: Cannabinoids in cancer treatment: Therapeutic potential and legislation
• Country: Slovenia
• Authors: Barbara Dariš, Mojca Tancer Verboten, Željko Knez, and Polonca Ferk
• Date: 2019 Feb 19

• Name: The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
• Country: Australia
• Authors: Yann Chye, Erynn Christensen, Nadia Solowij, and Murat Yücel
• Date: 2019 Feb 19

• Name: Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial
• Country: The Netherlands
• Authors: Febe E. van der Flier, Caroline M. B. Kwee, Danielle C. Cath, Neeltje M. Batelaan
• Date: 2019 Feb 13